LUCAS; Brian S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for LUCAS; Brian S..The latest application filed is for "processes of making and crystalline forms of a mdm2 inhibitor".
- LUCAS; Brian S. - Arlington MA
- Lucas; Brian S. - Thousand Oaks CA
- Lucas; Brian S. - San Francisco CA
- Lucas; Brian S. - Christianburg VA
| Patent | Date |
|---|---|
| Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor App 20220280496 - BIO; Matthew ; et al. | 2022-09-08 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ; et al. | 2022-06-02 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ; et al. | 2021-06-17 |
| Compounds that inhibit Mcl-1 protein Grant 11,001,598 - Lucas May 11, 2 | 2021-05-11 |
| Compounds That Inhibit Mcl-1 Protein App 20210040120 - LUCAS; Brian S. ; et al. | 2021-02-11 |
| Compounds that inhibit MCL-1 protein Grant 10,836,779 - Brown , et al. November 17, 2 | 2020-11-17 |
| Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor App 20200281912 - BIO; Matthew ; et al. | 2020-09-10 |
| Compounds That Inhibit Mcl-1 Protein App 20200062780 - BROWN; Sean P. ; et al. | 2020-02-27 |
| Heterocyclic Compounds And Their Uses App 20200048265 - CHEN; Yi ; et al. | 2020-02-13 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ; et al. | 2019-02-28 |
| Compounds That Inhibit Mcl-1 Protein App 20190023720 - BROWN; Sean P. ; et al. | 2019-01-24 |
| Compounds That Inhibit Mcl-1 Protein App 20190016736 - BROWN; Sean P. ; et al. | 2019-01-17 |
| Compounds that inhibit Mcl-1 protein Grant 10,100,063 - Brown , et al. October 16, 2 | 2018-10-16 |
| Heterocyclic Compounds And Their Uses App 20180105532 - CHEN; Yi ; et al. | 2018-04-19 |
| Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor App 20180092898 - BIO; Matthew ; et al. | 2018-04-05 |
| Heterocyclic compounds and their uses Grant 9,873,701 - Chen , et al. January 23, 2 | 2018-01-23 |
| Processes of making and crystalline forms of a MDM2 inhibitor Grant 9,801,867 - Bio , et al. October 31, 2 | 2017-10-31 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ; et al. | 2017-05-25 |
| Processes of making and crystalline forms of a MDM2 inhibitor Grant 9,623,018 - Bio , et al. April 18, 2 | 2017-04-18 |
| Compounds That Inhibit Mcl-1 Protein App 20170088560 - BROWN; Sean P. ; et al. | 2017-03-30 |
| Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
| Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor App 20160289243 - BIO; Matthew ; et al. | 2016-10-06 |
| Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor App 20160289190 - BIO; Matthew ; et al. | 2016-10-06 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ; et al. | 2016-05-19 |
| Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
| Compounds That Inhibit Mcl-1 Protein App 20160068545 - BROWN; Sean P. ; et al. | 2016-03-10 |
| Heterocyclic Compounds And Their Uses App 20150045361 - CHEN; Yi ; et al. | 2015-02-12 |
| Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor App 20140364455 - BIO; Matthew ; et al. | 2014-12-11 |
| Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ; et al. | 2014-10-23 |
| Heterocyclic compounds and their uses Grant 8,586,739 - Chen , et al. November 19, 2 | 2013-11-19 |
| EFPI sensor Grant 8,558,994 - Homa , et al. October 15, 2 | 2013-10-15 |
| Efpi Sensor App 20110170116 - Homa; Daniel S. ; et al. | 2011-07-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 